25 Jun, 2024 Biotech Review of the Year: Six months on By Bristows LLP It's hard to believe that six months have passed since we released the 11th edition of our Biotech Review of the Year publication. Our...
17 Jun, 2024 Crystal Palace the latest sports club to gamble with its reputation By Rob Powell Sponsorship revenues are fundamental to the very existence of sports clubs at all levels. They are undoubtedly among the biggest income...
13 Jun, 2024 Takeaways from the EU Pharma Law Forum 2024 By Jamie Hatzel Bristows was delighted to sponsor and attend this year’s EU Pharmaceutical Law Forum, which was held in Brussels at the Steigenberger...
11 Jun, 2024 Deal-making for cell and gene therapy companies: Insights from One Nucleus’ panel event By Claire Smith Luca Cericola Cell and gene therapies (CGTs) continue to hold considerable promise for the future of medicine, providing unprecedented therapeutic...
24 May, 2024 Clinical combinations: ever increasingly, two study products are better than one By Claire Smith Adam Coughlin Forgive the poetic licence but it feels like almost every week a new agreement for a clinical combination therapy lands on our desks....
22 May, 2024 Updated guidance on the NSIA published today By Samuel Munday Following on from the Government's consultation with stakeholders in relation to the National Security and Investment Act 2021 launched...
01 Nov, 2023 Bristows’ SnippITs – As the old phrase goes, Never Assume! – it’s commercial common sense By Adrian Sim This post is part of the Bristows’ SnippITs series, which pulls together the key practical takeaways from recent court decisions for the...
25 Oct, 2023 Bristows’ SnippITs – Make sure your drafting is tip-“Topalsson” By Adrian Sim Vivien Zhu This post is part of the Bristows’ SnippITs series, which pulls together the key practical takeaways from recent court decisions for the...
12 Oct, 2023 Guide to doing business in the UK By Emily Atkinson Samuel Munday Harry Woodcock This note provides a high-level overview of some of the key issues to consider when a non-UK business plans to expand into the UK.
20 Sep, 2023 My supplier is using AI in the delivery of its services: considerations for in-house lawyers By Rob Powell As software tools and solutions powered by AI become more prevalent and accessible, they are more frequently being used “in the...
18 Sep, 2023 First CRISPR therapy seeks regulatory approval, but will it be able to avoid the pitfalls of other cell and gene therapies? By Janna Lawrence Claire Smith Ellen Lambrix This article discusses the first CRISPR therapy seeks regulatory approval, raising the question but will it be able to avoid the pitfalls...
05 Jul, 2023 Spin-out trends: Views from the PraxisAuril conference By Erik Müürsepp Last month Adam Coughlin and Erik Müürsepp from Bristows’ Commercial IP team had the opportunity to attend the annual conference of...